CORONA
CORONA · Corporate filings
NSE
Financial Charts & Report quarterly revenue, profit, margins, growth, and price overlay
Stock market charts for CORONA quarterly results: revenue, profit, margins, growth, and filing-derived operating metrics.
Loading financial charts...
Financial Results figures in ₹ crore, except EPS/%
Loading…
Relative Returns vs Sector, Nifty 50, Sensex, Nifty 500
Loading…
CAN SLIM William O'Neil's growth-stock criteria
Loading…
Latest Shareholding Pattern promoter, FII, DII, public and institution trend
NSE synced data
Corporate Governance SEBI integrated governance filing
NSE synced data
Loading governance disclosure...
Announcements
Shareholders meeting
10 Jul 2026
Shareholders meeting
09 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
06 Jul 2026
Press Release
30 Jun 2026
Commencement of commercial production/operations
30 Jun 2026
Trading Window
29 Jun 2026
Copy of Newspaper Publication
16 Jun 2026
Updates
16 Jun 2026
Shareholders meeting
16 Jun 2026
Copy of Newspaper Publication
10 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
10 Jun 2026
Disclosure under SEBI Takeover Regulations
03 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
03 Jun 2026
Analysts/Institutional Investor Meet/Con. Call Updates
01 Jun 2026
Press Release
28 May 2026
News
Loading…
Corporate Actions dividends, bonuses, splits, buybacks, rights
Dividend - Rs 10 Per Share
Dividend - Rs 10 Per Share
Ex-date: 19 Jun 2026
Board Meetings
11 May 2026
CORONA REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 11-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
11 May 2026
To consider and approve the financial results for the period ended March 31, 2026 and recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2026.
02 Feb 2026
CORONA REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 .
02 Feb 2026
To consider and approve the financial results for the period ended December 31, 2025
02 Jan 2026
CORONA REMEDIES LIMITED has informed the Exchange about Board Meeting to be held on 02-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 .
02 Jan 2026
To consider and approve the financial results for the period ended September 30, 2025